According to the Huffington Post, scientists have recently zeroed in on a common feature in the brain receptors that play a role in pain, addiction, and memory loss.
Now in their latest study, Hamouda’s team was able to identify a structural difference in one type of receptor (the type that contributes to nicotine addiction, cognitive problems and pain), Hamouda said. That means such a drug might be effective in helping patients with all of these problems, he added. Though it’s important to note there is still a lot of work to do to design and develop the drug, and test it for all of these issues. An approved drug is still likely many years away.